Seven male\u00a0U.S. teenagers reported heart muscle inflammation after their second dose of the Pfizer-BioNTech vaccine, according to a study released on Friday, suggesting a \u201cpossible\u201d but unproven link between the condition and the vaccine.<\/p>\n
The research,\u00a0published in the journal Pediatrics<\/a>, highlighted seven cases of teenagers between 14 and 19 who developed symptoms for myocarditis days after receiving their second dose in April and May.<\/p>\n All reported chest pain within four days of the second shot, resolved their symptoms \u201crapidly\u201d and were sent home from the hospital after two to six days.<\/p>\n \u201cNo causal relationship\u201d:\u00a0<\/strong>The study is among the latest reports of young men developing symptoms of myocarditis after getting the Pfizer-BioNTech vaccine, although the report emphasized that \u201cno definite causal relationship\u201d has been proven and such cases \u201cappear rare.\u201d<\/p>\n \u201cNo causal relationship between vaccine administration and myocarditis has been established,\u201d the study said.<\/p>\n What\u2019s next:\u00a0<\/strong>Experts are now examining whether there are more cases of myocarditis after vaccination than are typical, though the CDC\u00a0recommends<\/a>\u00a0that those older than 12 still get vaccinated, warning that the risks of COVID-19 are greater than the shot.<\/p>\n